Clinical Trials Browser

Urinary Bladder Neoplasms, Bone Neoplasms, Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Glioblastoma, Hodgkin Disease, Kidney Neoplasms, Leukemia, Lung Neoplasms, Lymphoma, Lymphoma, Non-Hodgkin, Melanoma, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Osteosarcoma, Skin Neoplasms, Testicular Neoplasms, Thyroid Neoplasms, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Small Cell Lung Carcinoma

NCT01660633 2020-04-21

Safety & Efficacy Study High Dose Evomela Injection for MA Conditioning in MM Patients With Autologous Transplantation

Phase 2 Completed

61 enrolled

Plasma cell

Multiple Myeloma

NCT00925782 2019-12-17

PK Study of Melphalan HCL & Alkeran for Injection of MA Conditioning in MM Patients of Autologous Transplantation

Phase 2 Completed

24 enrolled 10 charts

Plasma cell

Multiple Myeloma

NCT03507166 2019-08-21

A Phase II Study of RC48-ADC in Subjects With HER2 Positive Metastatic or Unresectable Urothelial Cancer

Phase 2 Completed

43 enrolled

Genitourinary

Carcinoma, Transitional Cell

NCT03286296 2019-08-02

LZM009 to Treat Patients With Advanced Solid Tumors

Phase 1 Completed

30 enrolled

Other solid neoplasm

Solid Tumor

NCT02324335 2019-01-16

Brilacidin

Phase 2 Completed

61 enrolled 12 charts

Head & NeckOther

Head and Neck Neoplasms, Stomatitis, Mucositis

NCT02267083 2018-01-10

Efficacy and Safety Study of GPX-150 to Treat Soft Tissue Sarcoma

Phase 2 Completed

22 enrolled 10 charts

Sarcoma

NCT00711958 2017-09-05

Study to Assess the Efficacy and Safety of HX575 in the Treatment of Chemotherapy Associated Anemia in Cancer Patients

Phase 3 Completed

114 enrolled 10 charts

Classical hematology

Anemia

NCT01165905 2017-06-23

Safety of 24-hour Infusion of ON 01910.Na in Combination With Gemcitabine in Advanced Solid Tumors

Phase 1 Completed

10 enrolled

Tumor-Agnostic

Neoplasms

NCT01479244 2017-02-27

PRESENT

Phase 3 Completed

758 enrolled

Breast

Breast Neoplasms

NCT01837667 2017-01-24

Phase I Study of LB-100 With Docetaxel in Solid Tumors

Phase 1 Completed

29 enrolled

Tumor-Agnostic

Neoplasms

Clinical Trials

A Phase I /IIa Study of RC88-ADC in Subjects With Advanced Malignant Solid Tumors

RC88 in Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer

A Study of RC108-ADC in Subjects With Advanced Malignant Solid Tumors

Imaging Study to Investigate Safety and Diagnostic Performance of 18F rhPSMA 7.3 PET Ligand in Suspected Prostate Cancer Recurrence

A Study of SHR-1210± SHR-1020 Versus Chemotherapy in Patients With Recurrent or Metastatic Cervical Cancer

Double/Triple Combinations of AN2025, AN0025 and Atezolizumab in Advanced Solid Tumors

Blinded Cross-Over Bioequivalence (BE) Trial of Luitpold Azacitidine vs Vidaza

Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer.

Safety Study of Sterile Compound C31510 for Injection to Subjects With Solid Tumors

A Clinical Study to Compare the Efficacy, Safety and Immunogenicity of HLX04 and Bevacizumab Combined XELOX or mFOLFOX6 in the First-line Treatment of mCRC

Evaluating the Safety, Tolerability, and Pharmacokinetics of BAT1006

PREVLAR

Phase I/II Clinical Trial of LBL-015 for Injection

Safety Tolerability Pharmacokinetic and Preliminary Efficacy in Chinese Advanced Solid Tumors Patients

Evaluate Safety and Efficacy of High-dose Melphalan HCL for Injection in MM Patients With Auto-HSC Transplantation

ModraDoc006/r vs Docetaxel IV in Metastatic Prostate Cancer

Safety, Tolerability, PK, Anti-Tumor Activity of STP705 in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard Therapy

Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With Basal Cell Carcinoma

Clinical Trial of Dose-tolerance, Pharmacokinetics and Iodine Uptake For rhTSH In Post-thyroidectomized Patients

A Phase 2 Study of SP-02L in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

A Study of RC48-ADC in Subjects With HER2-negative Locally Advanced or Metastatic Urothelial Cancer

A Open-label, Single-arm, Multicenter, Phase II Study of RC48-ADC to Evaluate the Efficacy and Safety of Subjects With HER2 Overexpressing Locally Advanced or Metastatic Urothelial Cancer

Study of BEBT-908 in Subjects With Advanced Hematological Tumors

A Study of RC118 in Patients With Locally Advanced Unresectable/Metastatic Solid Tumours

Pharmacokinetics, Pharmacodynamics and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX®

OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules

Elucidate

Clinical Study to Compare the Pharmacokinetics and Safety of Trastuzumab for Injection With Herceptin® in Healthy Male Volunteers

APG-1387 in Patients With Advanced Solid Tumors or Hematologic Malignancies

A Pharmacokinetic Study Comparing EG1206A and Perjeta (Pertzumab) in Healthy Male Volunteers

IT-MATTERS

A Study to Evaluate the Safety and Efficacy of SHR-1210, Gemcitabine and Cis-platinum by R/M NPC Subjects

Phase 2 Study of OTL38 for Intra-operative Imaging of Folate Receptor-alpha Positive Ovarian Cancer

OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer

A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer Subjects With the Overexpression of HER2

A Bioequivalence Study of Docetaxel Injection in Patients With Solid Tumours

GARDENIA

Efficacy and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX®

A Phase Ⅲa Study of Genetically Modified Recombinant Human Interleukin-11

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

Safety & Efficacy Study High Dose Evomela Injection for MA Conditioning in MM Patients With Autologous Transplantation

PK Study of Melphalan HCL & Alkeran for Injection of MA Conditioning in MM Patients of Autologous Transplantation

A Phase II Study of RC48-ADC in Subjects With HER2 Positive Metastatic or Unresectable Urothelial Cancer

LZM009 to Treat Patients With Advanced Solid Tumors

Brilacidin

Efficacy and Safety Study of GPX-150 to Treat Soft Tissue Sarcoma

Study to Assess the Efficacy and Safety of HX575 in the Treatment of Chemotherapy Associated Anemia in Cancer Patients

Safety of 24-hour Infusion of ON 01910.Na in Combination With Gemcitabine in Advanced Solid Tumors

PRESENT

Phase I Study of LB-100 With Docetaxel in Solid Tumors